Efficacy and safety of benazepril for advanced chronic renal insufficiency.
By F. Hou, Xun Zhang, G. H. Zhang, D. Xie, Ping-yan Chen, Wei Zhang, Jian-ping Jiang, M. Liang, G. B. Wang, Zheng-rong Liu and 1 more. New England Journal of Medicine, 2006
627 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology
View Paper: https://www.semanticscholar.org/paper/5a8a8d7aae06bc51b43acb75a2b6e1b28cfcfdde
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nephrology
Citations in the corpus
- Renal tubule injury: a driving force toward chronic kidney disease. (2018, background): “Blockade of the RAS has become the mainstay therapy for the preservation of CKD.(90) Ang II is the major bioactive product of the RAS.”